Oral aluminum administration to rats with normal renal function. 2. Body distribution

Aluminum (Al) has no known physiological function and is not considered an essential dietary compound. Nowadays, it is recognized as an element that can produce adverse effects on biological systems. The present study determined Al partitioning in the body compartments of rats that have been orally...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human & experimental toxicology 1998-06, Vol.17 (6), p.318-322
Hauptverfasser: Garbossa, G., Gálvez, G., Pérez, G., Stripeikis, J., Tudino, M., Nesse, A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 322
container_issue 6
container_start_page 318
container_title Human & experimental toxicology
container_volume 17
creator Garbossa, G.
Gálvez, G.
Pérez, G.
Stripeikis, J.
Tudino, M.
Nesse, A.
description Aluminum (Al) has no known physiological function and is not considered an essential dietary compound. Nowadays, it is recognized as an element that can produce adverse effects on biological systems. The present study determined Al partitioning in the body compartments of rats that have been orally exposed for 15 weeks. Three experimental groups were studied: Controls (C, n=19), TAl-1 (n=10) rats receiving daily doses of Al citrate (1.0 micromol/g body weight) by gavage and TAl-2 (n=13), receiving Al citrate with the drinking water (100 mmol/ l). At the end of the experimental period, the Al contents of organs and sera were determined. Results are expressed as median and range values. Comparing the TAl-2 rats with the control ones, remarkable Al accumulation could be observed in serum (4.8/2.7-16.3 vs 0.4/0.2-1.2 micromol/l, P
doi_str_mv 10.1191/096032798678908828
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_220861550</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>791276231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-3b64284f309225afdf50691fb88e0db23a519cd32069f641cce8b634b847ac93</originalsourceid><addsrcrecordid>eNplkE9LxDAQxYMoWFe_gKfgvetk0qbJURf_wcJe1nNJ0wa7tM2aNMh-e1PWm5d5w-M3w-MRcs9gzZhij6AEcKyUFJVUICXKC5KxoqpyUMAvSbYAeSLYNbkJ4QAAQpUsI587rweqhzj2UxypbpP2YfZ67t1EZ0fTFuhPP3_Ryfkxsb6b0rRxMguyprimz6490XY565u4uLfkyuohdHd_uiL715f95j3f7t4-Nk_b3GCFc84bUaAsLAeFWGrb2jLFYraRsoO2Qa5LpkzLMblWFMyYTjaCF40sKm0UX5GH89ujd9-xC3N9cNGneKFGBClYWUKC8AwZ70Lwna2Pvh-1P9UM6qW8-n95_Bcgs2F-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220861550</pqid></control><display><type>article</type><title>Oral aluminum administration to rats with normal renal function. 2. Body distribution</title><source>SAGE Complete A-Z List</source><source>Alma/SFX Local Collection</source><creator>Garbossa, G. ; Gálvez, G. ; Pérez, G. ; Stripeikis, J. ; Tudino, M. ; Nesse, A.</creator><creatorcontrib>Garbossa, G. ; Gálvez, G. ; Pérez, G. ; Stripeikis, J. ; Tudino, M. ; Nesse, A.</creatorcontrib><description><![CDATA[Aluminum (Al) has no known physiological function and is not considered an essential dietary compound. Nowadays, it is recognized as an element that can produce adverse effects on biological systems. The present study determined Al partitioning in the body compartments of rats that have been orally exposed for 15 weeks. Three experimental groups were studied: Controls (C, n=19), TAl-1 (n=10) rats receiving daily doses of Al citrate (1.0 micromol/g body weight) by gavage and TAl-2 (n=13), receiving Al citrate with the drinking water (100 mmol/ l). At the end of the experimental period, the Al contents of organs and sera were determined. Results are expressed as median and range values. Comparing the TAl-2 rats with the control ones, remarkable Al accumulation could be observed in serum (4.8/2.7-16.3 vs 0.4/0.2-1.2 micromol/l, P<0.001), bone (3.33/1.78-4.85 vs 1.00/0.48-1.59 micromol/ g, P<0.001), kidney (2.33/0.96-3.15 vs 0.52/0.22-2.07 micromol/g, P<0.001), spleen (2.22/0.70-4.19 vs 0.27/ 0.11 - 0.36 micromol/g, P< 0.001) and liver (0.60/0.42-0.91 vs 0.24/0.14-0.78 micromol/g, P<0.01) while brain Al content was not significantly increased. Aluminum levels were raised in the TAl-1 group only in serum (2.8/1.3 - 10.4 micromol/ g, P < 0.001), bone (1.85/1.00-3.41 micromol/g, P < 0.001) and kidney (1.74/0.96-2.07 micromol/g, P<0.01). Bone Al concentration increased in a dose-dependent manner (TAl-2 vs TAl-1, P<0.001). The results demonstrate different tissue Al accumulation in rats chronically exposed to Al citrate, irrespective of their intact renal function.]]></description><identifier>ISSN: 0960-3271</identifier><identifier>EISSN: 1477-0903</identifier><identifier>DOI: 10.1191/096032798678908828</identifier><language>eng</language><publisher>London: Sage Publications Ltd</publisher><ispartof>Human &amp; experimental toxicology, 1998-06, Vol.17 (6), p.318-322</ispartof><rights>1998 Arnold</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c272t-3b64284f309225afdf50691fb88e0db23a519cd32069f641cce8b634b847ac93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Garbossa, G.</creatorcontrib><creatorcontrib>Gálvez, G.</creatorcontrib><creatorcontrib>Pérez, G.</creatorcontrib><creatorcontrib>Stripeikis, J.</creatorcontrib><creatorcontrib>Tudino, M.</creatorcontrib><creatorcontrib>Nesse, A.</creatorcontrib><title>Oral aluminum administration to rats with normal renal function. 2. Body distribution</title><title>Human &amp; experimental toxicology</title><description><![CDATA[Aluminum (Al) has no known physiological function and is not considered an essential dietary compound. Nowadays, it is recognized as an element that can produce adverse effects on biological systems. The present study determined Al partitioning in the body compartments of rats that have been orally exposed for 15 weeks. Three experimental groups were studied: Controls (C, n=19), TAl-1 (n=10) rats receiving daily doses of Al citrate (1.0 micromol/g body weight) by gavage and TAl-2 (n=13), receiving Al citrate with the drinking water (100 mmol/ l). At the end of the experimental period, the Al contents of organs and sera were determined. Results are expressed as median and range values. Comparing the TAl-2 rats with the control ones, remarkable Al accumulation could be observed in serum (4.8/2.7-16.3 vs 0.4/0.2-1.2 micromol/l, P<0.001), bone (3.33/1.78-4.85 vs 1.00/0.48-1.59 micromol/ g, P<0.001), kidney (2.33/0.96-3.15 vs 0.52/0.22-2.07 micromol/g, P<0.001), spleen (2.22/0.70-4.19 vs 0.27/ 0.11 - 0.36 micromol/g, P< 0.001) and liver (0.60/0.42-0.91 vs 0.24/0.14-0.78 micromol/g, P<0.01) while brain Al content was not significantly increased. Aluminum levels were raised in the TAl-1 group only in serum (2.8/1.3 - 10.4 micromol/ g, P < 0.001), bone (1.85/1.00-3.41 micromol/g, P < 0.001) and kidney (1.74/0.96-2.07 micromol/g, P<0.01). Bone Al concentration increased in a dose-dependent manner (TAl-2 vs TAl-1, P<0.001). The results demonstrate different tissue Al accumulation in rats chronically exposed to Al citrate, irrespective of their intact renal function.]]></description><issn>0960-3271</issn><issn>1477-0903</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNplkE9LxDAQxYMoWFe_gKfgvetk0qbJURf_wcJe1nNJ0wa7tM2aNMh-e1PWm5d5w-M3w-MRcs9gzZhij6AEcKyUFJVUICXKC5KxoqpyUMAvSbYAeSLYNbkJ4QAAQpUsI587rweqhzj2UxypbpP2YfZ67t1EZ0fTFuhPP3_Ryfkxsb6b0rRxMguyprimz6490XY565u4uLfkyuohdHd_uiL715f95j3f7t4-Nk_b3GCFc84bUaAsLAeFWGrb2jLFYraRsoO2Qa5LpkzLMblWFMyYTjaCF40sKm0UX5GH89ujd9-xC3N9cNGneKFGBClYWUKC8AwZ70Lwna2Pvh-1P9UM6qW8-n95_Bcgs2F-</recordid><startdate>19980601</startdate><enddate>19980601</enddate><creator>Garbossa, G.</creator><creator>Gálvez, G.</creator><creator>Pérez, G.</creator><creator>Stripeikis, J.</creator><creator>Tudino, M.</creator><creator>Nesse, A.</creator><general>Sage Publications Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7ST</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>SOI</scope></search><sort><creationdate>19980601</creationdate><title>Oral aluminum administration to rats with normal renal function. 2. Body distribution</title><author>Garbossa, G. ; Gálvez, G. ; Pérez, G. ; Stripeikis, J. ; Tudino, M. ; Nesse, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-3b64284f309225afdf50691fb88e0db23a519cd32069f641cce8b634b847ac93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Garbossa, G.</creatorcontrib><creatorcontrib>Gálvez, G.</creatorcontrib><creatorcontrib>Pérez, G.</creatorcontrib><creatorcontrib>Stripeikis, J.</creatorcontrib><creatorcontrib>Tudino, M.</creatorcontrib><creatorcontrib>Nesse, A.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Environment Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environment Abstracts</collection><jtitle>Human &amp; experimental toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Garbossa, G.</au><au>Gálvez, G.</au><au>Pérez, G.</au><au>Stripeikis, J.</au><au>Tudino, M.</au><au>Nesse, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral aluminum administration to rats with normal renal function. 2. Body distribution</atitle><jtitle>Human &amp; experimental toxicology</jtitle><date>1998-06-01</date><risdate>1998</risdate><volume>17</volume><issue>6</issue><spage>318</spage><epage>322</epage><pages>318-322</pages><issn>0960-3271</issn><eissn>1477-0903</eissn><abstract><![CDATA[Aluminum (Al) has no known physiological function and is not considered an essential dietary compound. Nowadays, it is recognized as an element that can produce adverse effects on biological systems. The present study determined Al partitioning in the body compartments of rats that have been orally exposed for 15 weeks. Three experimental groups were studied: Controls (C, n=19), TAl-1 (n=10) rats receiving daily doses of Al citrate (1.0 micromol/g body weight) by gavage and TAl-2 (n=13), receiving Al citrate with the drinking water (100 mmol/ l). At the end of the experimental period, the Al contents of organs and sera were determined. Results are expressed as median and range values. Comparing the TAl-2 rats with the control ones, remarkable Al accumulation could be observed in serum (4.8/2.7-16.3 vs 0.4/0.2-1.2 micromol/l, P<0.001), bone (3.33/1.78-4.85 vs 1.00/0.48-1.59 micromol/ g, P<0.001), kidney (2.33/0.96-3.15 vs 0.52/0.22-2.07 micromol/g, P<0.001), spleen (2.22/0.70-4.19 vs 0.27/ 0.11 - 0.36 micromol/g, P< 0.001) and liver (0.60/0.42-0.91 vs 0.24/0.14-0.78 micromol/g, P<0.01) while brain Al content was not significantly increased. Aluminum levels were raised in the TAl-1 group only in serum (2.8/1.3 - 10.4 micromol/ g, P < 0.001), bone (1.85/1.00-3.41 micromol/g, P < 0.001) and kidney (1.74/0.96-2.07 micromol/g, P<0.01). Bone Al concentration increased in a dose-dependent manner (TAl-2 vs TAl-1, P<0.001). The results demonstrate different tissue Al accumulation in rats chronically exposed to Al citrate, irrespective of their intact renal function.]]></abstract><cop>London</cop><pub>Sage Publications Ltd</pub><doi>10.1191/096032798678908828</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-3271
ispartof Human & experimental toxicology, 1998-06, Vol.17 (6), p.318-322
issn 0960-3271
1477-0903
language eng
recordid cdi_proquest_journals_220861550
source SAGE Complete A-Z List; Alma/SFX Local Collection
title Oral aluminum administration to rats with normal renal function. 2. Body distribution
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A30%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20aluminum%20administration%20to%20rats%20with%20normal%20renal%20function.%202.%20Body%20distribution&rft.jtitle=Human%20&%20experimental%20toxicology&rft.au=Garbossa,%20G.&rft.date=1998-06-01&rft.volume=17&rft.issue=6&rft.spage=318&rft.epage=322&rft.pages=318-322&rft.issn=0960-3271&rft.eissn=1477-0903&rft_id=info:doi/10.1191/096032798678908828&rft_dat=%3Cproquest_cross%3E791276231%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=220861550&rft_id=info:pmid/&rfr_iscdi=true